Arkolith/Insider Trading/HRTX/Form 4

Duarte Ira

EVP, Chief Financial OfficerHERON THERAPEUTICS, INC. /DE/ (HRTX) · full profile →Form 4 · filed Jun 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Option exercise(M)13K——265K
Jun 16, 2026Tax withholding(F)4K$0.38$1K261K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 16, 2026Option exercise(M)13K—$013K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-273552) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML